Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0NS9C
|
||||
Former ID |
DIB004989
|
||||
Drug Name |
BIIB-513
|
||||
Synonyms |
BIIB-513; NHE-1 inhibitors (myocardial infarction/reperfusion injury); NHE-1 inhibitors (myocardial infarction/reperfusion injury), Boehringer Ingelheim
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Myocardial infarction [ICD9: 410; ICD10:I21, I22] | Investigative | [543981] | ||
Company |
Boehringer Ingelheim Corp
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H25N5O8S2
|
||||
Canonical SMILES |
FC(F)(c1c(C2CCN(CC2)C(=O)C)ccc(c1)C(=O)NC(=N)N)F
|
||||
CAS Number |
CAS 193401-08-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium/hydrogen exchanger 1 | Target Info | Inhibitor | [543981] | |
Pathway Interaction Database | Endothelins | ||||
RhoA signaling pathway | |||||
ErbB1 downstream signaling | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
Reactome | Hyaluronan uptake and degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.